Product image of Konaten (Atomoxetine) supplied by GNH India

Konaten

Active Ingredient:
Atomoxetine
Origin:
EU

Konaten (Atomoxetine)

Atomoxetine, the active ingredient in Konaten, is a selective norepinephrine reuptake inhibitor (SNRI) presented as an oral formulation for oral use. It is indicated for the treatment of attention deficit hyperactivity disorder (ADHD) in children, adolescents, and adults.

GNH India supplies Konaten as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Neuraxpharm Arzneimittel Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Atomoxetine is used in the management of attention deficit hyperactivity disorder (ADHD) by modulating norepinephrine pathways.

  • Attention deficit hyperactivity disorder (ADHD) in children and adolescents: Improves attention and reduces hyperactivity and impulsivity.
  • Attention deficit hyperactivity disorder (ADHD) in adults: Helps control core symptoms and improve daily functioning.
  • ADHD with comorbid anxiety: May alleviate anxiety symptoms associated with ADHD.

How It Works

  • Atomoxetine selectively inhibits the norepinephrine transporter (NET), preventing reuptake of norepinephrine into presynaptic neurons. This increases extracellular norepinephrine concentrations, particularly in the prefrontal cortex, enhancing attention, executive function, and impulse control without directly affecting dopamine pathways.

Side Effects

Atomoxetine may cause a range of adverse reactions, from mild to serious.

Common Side Effects

  • Nausea: mild to moderate gastrointestinal upset.
  • Decreased appetite: reduced food intake, especially early in therapy.
  • Dry mouth: sensation of oral dryness.
  • Insomnia: difficulty falling or staying asleep.
  • Dizziness: transient light‑headedness.
  • Fatigue: feeling unusually tired.

Serious or Rare Side Effects

  • Suicidal ideation: emergence of thoughts of self‑harm.
  • Liver injury: signs of hepatitis or elevated liver enzymes.
  • Severe allergic reaction: rash, swelling, or anaphylaxis.
  • Increased blood pressure or heart rate: hypertension or tachycardia.
  • Psychosis or mania: emergence of severe psychiatric symptoms.
  • Cardiac arrhythmias: irregular heart rhythms.

Precautions & Warnings

Before initiating Atomoxetine, several safety considerations should be addressed.

  • Cardiovascular assessment: evaluate blood pressure and heart rate.
  • Psychiatric monitoring: watch for mood changes, suicidal thoughts, or aggression.
  • Glaucoma caution: avoid in patients with narrow‑angle glaucoma.
  • MAOI interaction: do not co‑administer with monoamine oxidase inhibitors within 14 days.
  • Discontinuation: taper under medical supervision to avoid withdrawal effects.
  • Store at room temperature below 25°C: keep in the original pack, protect from moisture.

Avoid Interactions

Atomoxetine can interact with several drug classes, requiring careful management.

Major Interactions (Avoid)

  • Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis.
  • Strong CYP2D6 inhibitors (e.g., fluoxetine, paroxetine): increase atomoxetine plasma levels.
  • Other norepinephrine reuptake inhibitors: additive sympathomimetic effects.

Moderate Interactions (Monitor Closely)

  • Antihypertensive agents: may reduce blood‑pressure control.
  • Central nervous system stimulants: may increase side‑effect burden such as insomnia or anxiety.

Frequently Asked Questions

Konaten contains atomoxetine, which is prescribed for the treatment of attention deficit hyperactivity disorder (ADHD) in children, adolescents, and adults. It helps improve attention, reduce hyperactivity, and control impulsive behavior by increasing norepinephrine levels in the brain.

Atomoxetine selectively blocks the norepinephrine transporter, preventing the reuptake of norepinephrine into nerve cells. This raises extracellular norepinephrine concentrations, especially in the prefrontal cortex, enhancing focus, executive function, and impulse control without directly stimulating dopamine pathways.

The appropriate dose of Konaten is determined by the prescribing clinician based on the patient’s age, weight, and clinical response. Dosage adjustments are made according to individual tolerability and therapeutic goals, and patients should follow the prescriber’s instructions precisely.

Safety data for atomoxetine in pregnancy and lactation are limited. Healthcare providers should weigh the potential benefits against possible risks and discuss alternative treatment options. Women who are pregnant, planning pregnancy, or breastfeeding should consult their physician before using Konaten.

To request Konaten, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and necessary import documentation.

Konaten (atomoxetine) is a non‑stimulant ADHD therapy, differing from stimulant options such as methylphenidate or amphetamines. It targets norepinephrine reuptake rather than dopamine release, which may be preferable for patients who cannot tolerate stimulants or have comorbid conditions that contraindicate stimulant use.

Konaten should be stored at room temperature below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure it is out of reach of children.

Konaten is taken orally, usually once daily in the morning. The tablet should be swallowed whole with water and not chewed or crushed, unless otherwise directed by a healthcare professional.

Serious risks include the emergence of suicidal thoughts, severe liver injury, significant increases in blood pressure or heart rate, and rare allergic reactions such as anaphylaxis. Patients should be monitored regularly for these events, and any concerning symptoms should prompt immediate medical evaluation.

Konaten is contraindicated in patients with known hypersensitivity to atomoxetine, those taking monoamine oxidase inhibitors within the past 14 days, and individuals with narrow‑angle glaucoma. Caution is also advised for patients with uncontrolled hypertension, severe cardiac disease, or a history of severe psychiatric disorders.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Atomoxetine

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT